Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001366446 | SCV001562748 | benign | not provided | 2024-07-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004978229 | SCV005569430 | uncertain significance | Inborn genetic diseases | 2024-10-08 | criteria provided, single submitter | clinical testing | The c.8007G>C (p.Q2669H) alteration is located in exon 108 (coding exon 108) of the COL7A1 gene. This alteration results from a G to C substitution at nucleotide position 8007, causing the glutamine (Q) at amino acid position 2669 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001278915 | SCV001465961 | uncertain significance | Epidermolysis bullosa dystrophica inversa, autosomal recessive | 2020-07-02 | no assertion criteria provided | clinical testing |